X

Trial Profile

A Phase 1 clinical trial for WVE-007 in adults living with overweight or obesity

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 27 Dec 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs WVE 007 (Primary)
Indications Obesity; Overweight
Focus Adverse reactions; First in man

Most Recent Events

23 Dec 2024 According to a Wave Life Sciences media release, the company announced the submission of its first clinical trial application (CTA) for WVE-007 in obesity and expects CTA approval and initiation of the first-in-human study of WVE-007 in the first quarter of 2025.
12 Nov 2024 According to Wave Life Sciences media release, clinical trial on track for 1Q 2025.
04 Nov 2024 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com